Fulltext

The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine

Hoff E 1 , Marcus R 2 , Bojko MJ 2 , Makarenko I 3 , Mazhnaya A 4 , Altice FL 5 Show all authors , Meyer JP 6

Affiliations 

  • 1 Yale School of Medicine, New Haven, CT, United States
  • 2 Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, United States
  • 3 Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, United States; ICP Alliance for Public Health, Kyiv, Ukraine
  • 4 ICP Alliance for Public Health, Kyiv, Ukraine; Johns Hopkins School of Public Health, Department of Health, Behavior and Society, Baltimore, MD, USA
  • 5 Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, United States; Yale School of Public Health, Epidemiology of Microbial Diseases, New Haven, CT, United States; University of Malaya, Kuala Lumpur, Malaysia
  • 6 Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, United States. Electronic address: Jaimie.meyer@yale.edu
J Subst Abuse Treat, 2017 Dec;83:36-44.
PMID: 29129194 DOI: 10.1016/j.jsat.2017.10.003

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications